Position in DGX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$815,371
+$58,889 QoQ
Shares Held
3,847
-0.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#527
of 1,090 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Savvy Advisors, Inc. holds $3,865,622 across 7 Diagnostics & Research names. DGX ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,084 | $1,044,834 | |
| 2 | DGX |
Quest Diagnostics Inc
This page
|
3,847 | $815,371 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,265 | $665,946 | |
| 4 | DHR |
Danaher Corp /De/
|
2,681 | $510,676 | |
| 5 | GH |
Guardant Health, Inc.
|
2,120 | $318,063 | |
| 6 | TWST |
Twist Bioscience Corp
|
2,511 | $258,331 | |
| 7 | WAT |
Waters Corp /De/
|
673 | $252,401 |
All Filings in DGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $815,371 | 3,847 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $756,482 | 3,860 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $542,107 | 3,124 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $563,163 | 2,955 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $472,067 | 2,628 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $373,593 | 2,208 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $300,513 | 1,992 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||